Extensions

Analysis of U.S. Patent 10,347,248

Date of Analysis: May 8, 2026

This report details the term adjustments, application history, and projected expiration date for U.S. Patent 10,347,248.

Patent Term Adjustments (PTA) and Extensions (PTE)

• Patent Term Adjustment (PTA): A review of the patent's file history on the USPTO's Patent Center indicates that there has been no Patent Term Adjustment granted for this patent. The front page of the issued patent, under the section "(45) Date of Patent," does not list any PTA days.
• Patent Term Extension (PTE): There is no indication of any Patent Term Extension under 35 U.S.C. § 156, which typically applies to delays in regulatory review for products like pharmaceuticals and is not relevant to this technology.

Continuation and Divisional Applications

A search for continuity data related to the application for this patent (U.S. Application No. 15/477,179) reveals a chain of related applications. This patent is part of a larger family of applications that claim priority to earlier filings.

• This Application (15/477,179): This is a continuation of application Ser. No. 14/569,820, filed on Dec. 14, 2014, which is now U.S. Pat. No. 9,646,659.
• Parent Applications:
  • The '820 application is a continuation of Ser. No. 14/065,585, filed on Oct. 29, 2013, now U.S. Pat. No. 8,942,987.
  • The '585 application is a continuation of Ser. No. 13/461,855, filed on May 2, 2012, now U.S. Pat. No. 8,595,005.
  • The '855 application is a continuation of Ser. No. 12/031,349, filed on Feb. 14, 2008, now U.S. Pat. No. 8,190,434.
• Provisional Application: The chain claims priority to U.S. Provisional Application No. 60/889,484, filed on Feb. 12, 2007.

This extensive continuation history indicates a long-term strategic effort to protect various aspects of the core invention. There are no divisional applications directly noted for application 15/477,179.

Patent Family Members

This U.S. patent is part of a larger international patent family. A search of the INPADOC database reveals related filings in other jurisdictions, indicating the global scope of the assignee's patent strategy. Key family members include:

• U.S. Patents: As noted above, the continuation chain includes U.S. Pat. Nos. 9,646,659; 8,942,987; 8,595,005; and 8,190,434.
• U.S. Patent Application Publications: Numerous publications are associated with the parent applications, including US 2008/0228491 A1 and others from the continuation chain.
• International Counterparts: While a comprehensive list is extensive, related applications have been identified in major patent offices, including the European Patent Office (EPO) and via the Patent Cooperation Treaty (PCT), suggesting filings in Europe, China, and other key markets.

Projected Expiration Date

The term of a U.S. patent filed after June 8, 1995, is twenty years from the filing date of the earliest U.S. or PCT application to which priority is claimed, excluding provisional applications.

1. Earliest Non-Provisional Filing Date: The patent claims priority to a chain of applications, with the earliest non-provisional filing being February 14, 2008 (from application Ser. No. 12/031,349).
2. Standard 20-Year Term Calculation: Adding 20 years to the earliest filing date:
   • February 14, 2008 + 20 years = February 14, 2028.
3. Applying Adjustments:
   • PTA: 0 days.
   • PTE: 0 days.
   • Terminal Disclaimers: No terminal disclaimers have been filed that would shorten the patent's term.

Therefore, the projected expiration date for U.S. Patent 10,347,248 is February 14, 2028. This assumes that all required maintenance fees are paid on schedule.